Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
---|---|---|---|---|---|---|
Mylan | Cysteamine | Cystagon |  | 1994-08-15 |  |  |
Horizon Therapeutics Public | Cysteamine | Procysbi | 2027-01-26 | 2013-04-30 | $216.321 M | Q3/22-Q2/23 |
Chiesi Farmaceutici | Cysteamine | Procysbi |  | 2013-09-05 |  |  |
Recordati | Cysteamine | Cystadrops |  | 2020-08-19 |  |  |
Cysteamine | Cystagon |  | 1997-06-23 |  |  | |
Leadiant Biosciences | Cysteamine | Cystaran |  | 2012-10-02 |  |  |
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
---|---|---|---|---|---|